The medical company Adonis has begun implementing a strategy for the development of its franchise network.
General Director of the company Vitaliy Hyrin told Interfax-Ukraine that the strategy is being implemented in two formats – a medical center and points for collection of laboratory tests.
“We have two options: a small medical center with an outpatient appointment, or a collection point – a manipulation room. They will work under our Adonis brand and comply with all the rules and requirements of corporate culture. At the same time, we will control our franchisees,” he said.
According to Hyrin, Adons has already attracted three franchise partners to open a large medical center with surgery and two collection points. By the end of the year, it is planned to open up to ten collection points in different regions of the country.
Answering the question of who can be the Adonis franchisee, Hyrin said that it can be “both people from medicine, as well as people from outside the healthcare sector, whom we are ready to accompany and to help.”
“Among our potential franchisees may be medical workers, for example, a doctor who wants to open his office, or a medical facility. We are ready to help at any stage, from obtaining a license to supporting operational activities. Also, our franchisees can be owners of premises who want to develop a medical business in them. In this case, we are ready to help with all medical issues. The only condition: our partner must understand that he will be engaged in the development of his business, this is not about making passive investments,” he said.
Adonis is a network of private full-cycle medical centers for adults and children.
The private clinic Adonis was established over 20 years ago. Its network includes ten branches in Kyiv and the region, including two of its own maternity hospitals and a stem cell laboratory. In the branches of the clinic, doctors conduct appointments in 60 medical directions.
The profits of ports should be returned to the cities in which they are located for the development of their infrastructure, Mykolaiv Mayor Oleksandr Senkevych has told Interfax-Ukraine on the sidelines of the International Mayors Summit (IMS).
“Mykolaiv was a city of shipbuilders. Now the factories are standing idle, Mykolaiv has turned into a port city. However, we do not receive money from the port infrastructure to the local budget, except for personal income tax and land lease,” Senkevych said.
He recalled that last year the net profit of the Ukrainian Sea Ports Authority amounted to more than UAH 2.6 billion.
“I think that this amount needs to be “halved.” Half of the profits is to be divided between the port cities, in proportion to the transshipment of goods. Cities should receive a portion of what they have earned for the country. Then we will be able to restore our infrastructure,” he said.
In his opinion, it will be possible to talk about the restoration of production and the attraction of significant investments in shipbuilding after the adoption of a law on technology parks. Senkevych considers promising a mechanism for the establishment of tax credits and preferential rates by local governments.
“Roughly speaking: they built a plant for EUR 100 million, you are provided with a tax credit for 50% of this amount for five to seven years. Personal income tax and land tax are paid from this amount. It is profitable for the enterprise to work officially, pay high salaries to employees,” Senkevych said.
The development of R&D and product portfolio will become one of the key aspects of the new development strategy of Farmak pharmaceutical company (Kyiv) until 2028.
The company told Interfax-Ukraine that along with these areas, Farmak will focus on launching the Biotech area, entering the U.S. market and strengthening its positions in the CIS countries.
“The new strategy is based on four key priorities for the development of the enterprise: take the position of an unattainable leader in Ukraine, consolidate and develop success in the CIS countries, become a successful player in the global market, strengthen the employer’s brand and be a company employing the best market specialists,” it said.
Farmak noted that in previous years, investments were made in production facilities.
“Now the company operates a new modern aseptic production, the equipment of six workshops has been updated, a new plant for the production of APIs has been opened in Shostka (Sumy region). The key aspects of the new strategy are the development of R&D and product portfolio, the launch of the Biotech direction, entry into the U.S. market and the strengthening of positions in the CIS countries,” the company said.
It is specified that Farmak will continue its strategy of reinvesting in development up to 90% of the received profit. The overall dynamics demonstrates the annual growth of the company’s financial indicators. Capital investments in 2020 amounted to UAH 1.3 billion, which is 78% more than in 2019. In the first half of 2021, sales revenue shows an increase of 28.3% compared to 2020, capital investments amounted to UAH 756 million, which is 12% more than in the first half of 2020.
In addition, the company stressed the importance of human resource development.
“The transformation of the company into an international one requires the involvement of specialists with unique knowledge, so it is necessary that all employees have a high level of English proficiency. Now it is planned to create international teams and exchange of personnel between the parent company and subsidiaries. This will help synchronize and strengthen the teams, provide new knowledge and will open up new horizons for the implementation of the set goals,” Farmak said.
As specified, in the course of implementing the strategy, Farmak plans to increase the global export of target products.
“Since the beginning of the year, the company has extended its presence in Latin America, opened an office in the UAE and a representative office in Vietnam. In the future, an even larger-scale entry into international markets is planned. One of the most important steps is entering the U.S. market, as well as the localization of business in Uzbekistan, which occupies 50% of the structure of shipments to the CIS countries,” Farmak added.
In addition, it is planned to improve the portfolio through a focus on new drugs.
“Farmak sees the future in the development of modern, high-tech drugs. In 2023, it is planned to open a new R&D center, which will significantly expand the scientific base, will allow developing drugs that are in demand all over the world, for example, developing an oncological portfolio. Special attention will be paid to for the launch of the Biotech direction. In matters of biotechnological medicines Farmak closely cooperates with consultants from Germany, Spain and the United States,” the company stressed.
In addition, the company noted the role of total digitalization of production processes. In particular, in the coming years, a complete transition to electronic quality certificates, electronic research protocols, electronic dossiers, and e-serialization of products is planned.
As reported, in September 2021, Farmak presented the new development strategy “Farmak 2.0: from local to global success.” A detailed plan has been developed until 2028, the main goal of which is transformation from a local leader into an international company.
Farmak is the leader of the Ukrainian pharmaceutical market. The product portfolio includes more than 220 complex component modern medicines. Among the main directions are endocrinological, gastroenterological, cardiological, neurological, anti-cold and other drugs.
The Cabinet of Ministers of Ukraine on Wednesday approved the draft decree on the signing of an agreement between the government of Ukraine and the government of the United States on projects in the field of research, developments, testing and evaluation, the authority to sign the agreement was given to Minister of Defense of Ukraine Andriy Taran, according to the Press and Information Office of the Ukrainian Defense Ministry.
“The signing of this agreement will give the Ukrainian side the opportunity to: conduct joint research and development work on the development of weapons and military equipment, their individual components; obtain information about advanced defense technologies, trends in their development; conduct of tests and testing of military equipment using equipment and technologies that are not available in Ukraine,” the office said.
The agreement also opens up the possibility of attracting foreign funding for research work by Ukrainian research institutions, as well as increasing the research potential of Ukraine through cooperation with partners in joint projects.
The ministry said that the implementation of the agreements will take place under project contracts within the framework of the agreement concluded between the Ministry of Defense of Ukraine and the U.S. Department of Defense.
“The signing of the Agreement is planned during the visit of the President of Ukraine to the United States and will be another important step in the development of strategic partnership with the United States in the field of armaments,” the Defense Ministry said.
The profile ministries of Ukraine and Lithuania have agreed to launch a pilot project to develop multimodal transportation between the countries, according to the website of the Ministry of Infrastructure of Ukraine on Thursday.
In Klaipeda, Lithuania, a meeting was held between Minister of Infrastructure of Ukraine Oleksandr Kubrakov and Minister of Transport and Communications of Lithuania Marius Skuodis, during which the parties discussed issues of strengthening cooperation and prospects for new projects.
“Partnership in the field of transport is one of the priorities. We are restoring a dialogue on the implementation of an old idea – connecting the Baltic and Black Sea regions by rail. For both countries this is a chance to optimize logistics, increase the load on seaports and enter new world markets. We have already agreed to launch a pilot project, within the framework of which we will develop multimodal traffic between countries, including by increasing the flow of semi-trailers,” Kubrakov is quoted as saying.
He also noted the relevance of the resumption of the passenger railway route “four capitals” from Kyiv to Riga.
According to the Ministry of Infrastructure, there are currently large cargo flows between the Baltic and Black Sea regions, but the share of cargo moving from Ukraine is very low. At Klaipeda seaport, Ukrainian cargo accounts for only about 1-2% of all cargo. At the same time, according to the estimates of the Lithuanian side, the flow of goods from Ukraine could potentially be 10 times higher.
“For the implementation of multimodal cargo transportation by sea and rail, road semi-trailers will also be used as intermodal transport units. To make this possible, the ministry will initiate amendments to Ukrainian legislation, which will allow semi-trailers to be classified as cargo, and not as a vehicle,” the report said.
The launch of the pilot project is planned for September this year.
The successful implementation of the agreement, as noted in the Ministry of Infrastructure, has the potential to make Klaipeda seaport in Lithuania the northern gateway of Ukraine to Scandinavia and at the same time Odesa – the southern sea gate of Lithuania to the Black Sea region.
The Global Affairs Canada, implementing the Ukraine Horticulture Business Development Project (UHBDP), has decided to extend the project until March 31, 2022, whereas it was previously planned to be completed in 2021, project manager Dmytro Nikolayev said during a press conference in Kyiv. According to him, UHBDP for the period from 2014 to 2021 provided financial support for a total of UAH 43.25 million for 2,780 clients.
He clarified that by March 31, 2022, the project will additionally support clients under various programs in the amount of about UAH 20 million. He clarified that at present UHBDP focused on informing farmers about the legislative features of the land market launched from July 1, developing and implementing educational and online trading platforms, and providing grants for business restoration to the most vulnerable groups of agricultural producers.
As reported, UHBDP finances 30% of the total cost of projects, which are at least estimated at $ 200,000. The term of their implementation is a year and a half.
The Ukraine Horticulture Business Development Project (UHBDP) is funded by the Global Affairs Canada, implemented and co-financed by the Mennonite Economic Development Associates (MEDA). MEDA works with Israel’s Agency for International Development Cooperation(MASHAV) and international service companies to provide technical support.
UHBDP works with producers from Zaporizhia, Kherson, Mykolaiv and Odesa regions, engaged in fruit and vegetable growing, berry growing, viticulture and beekeeping.